RxDoctor Payments Data

Marta Banegas

Child & Adolescent Psychiatry · Chicago, ILNPI 1477542926

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $457 and has fallen 86.8% since, to $60 in 2025.

$1,877in general payments, 2019–2025

Across 85 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$375
  • AbbVie$263
  • Johnson & Johnson$227
  • Alkermes, Inc.$141
  • Supernus Pharmaceuticals, Inc.$136
  • Otsuka America Pharmaceutical, Inc.$131
  • plus $604 from 15 others

What the payments were for

  • Food & beverage$1,877100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,877 in reported general payments places this provider in the 80th percentile of 124 child & adolescent psychiatry providers in Illinois.

See all child & adolescent psychiatry providers in Illinois

Other child & adolescent psychiatry in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →